Qube Research & Technologies (QRT)’s Ionis Pharmaceuticals IONS Stock Holding History

Qube Research & Technologies (QRT)’s Portfolio IONS Stock Details IONS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$26.5M	Buy	333,952 +291,096	+679%	+$21.9M	0.02%	779
2026 Q1	$3.22M	Buy	+42,856	New	+$3.38M	﹤0.01%	1894
2023 Q1	–	Sell	-330,724	Closed	-$12.5M	–	2772
2022 Q4	$12.5M	Buy	330,724 +319,027	+2,727%	+$13.4M	0.07%	416
2022 Q3	$517K	Buy	+11,697	New	+$493K	﹤0.01%	1454
2020 Q4	–	Sell	-131,618	Closed	-$6.25M	–	1997
2020 Q3	$6.25M	Buy	+131,618	New	+$7.31M	0.09%	295
2020 Q2	–	Sell	-11,225	Closed	-$531K	–	1853
2020 Q1	$531K	Buy	11,225 +5,508	+96%	+$307K	0.02%	551
2019 Q4	$345K	Buy	+5,717	New	+$341K	0.01%	1153

Other funds holding IONS

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return

Royal Bank of Canada Toronto, Ontario, Canada $672B AUM 33.48% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

T. Rowe Price Investment Management Baltimore, Maryland $153B AUM 38.14% 1-Year Est. Return

Qube Research & Technologies (QRT)'s IONS Position: Q2 2026 in Review

Qube Research & Technologies (QRT) increased its Ionis Pharmaceuticals (IONS) stake by 679% in Q2 2026, buying an estimated $21.9M and bringing the position to 333,952 shares worth $26.5M. The position accounts for 0.02% of the portfolio, ranked #779.

Qube Research & Technologies (QRT) first reported a position in IONS in Q4 2019 and has held it in 7 quarters since. 514 funds tracked by Wall St. Rank hold IONS as of Q2 2026.

Qube Research & Technologies (QRT) held 333,952 shares of Ionis Pharmaceuticals worth $26.5M as of Q2 2026.
Qube Research & Technologies (QRT) bought 291,096 Ionis Pharmaceuticals shares in Q2 2026, an estimated $21.9M.
Ionis Pharmaceuticals made up 0.02% of Qube Research & Technologies (QRT)'s portfolio in Q2 2026, its #779 holding.
Qube Research & Technologies (QRT) first reported a position in Ionis Pharmaceuticals in Q4 2019 and has held it in 7 quarters since.
514 funds tracked by Wall St. Rank held Ionis Pharmaceuticals as of Q2 2026.

Based on Qube Research & Technologies (QRT)'s 13F filing for Q2 2026, filed 14 Aug 2026.